Faculty

Print Friendly
DouglasReintgen

Douglas Reintgen

Professor, College Of Medicine Surgery

College Of Medicine Surgery

Academic Email: dreintge@health.usf.edu

Education

  • MD, Medicine, Duke University School Of Medicine, 1979

Recent Publications

  • Egger, ME.Bower, MR.Czyszczon, IA.Farghaly, H.Noyes, RD.Reintgen, DS.Martin, RC.Scoggins, CR.Stromberg, AJ.McMasters, KM. Comparison of sentinel lymph node micrometastatic tumor burden measurements in melanoma. Journal of the American College of Surgeons. 218(4) : 519-28, 2014. http://www.ncbi.nlm.nih.gov/pubmed/24491245
  • Matz, D.Kerivan, L.Reintgen, M.Akman, K.Lozicki, A.Causey, T.Clynes, C.Giuliano, R.Acs, G.Cox, J.Cox, C.Reintgen, D. Breast preservation in women with giant juvenile fibroadenoma. Clinical breast cancer. 13(3) : 219-22, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23245878
  • Reintgen, M.Murray, L.Akman, K.Giuliano, R.Lozicki, A.Shivers, S.Reintgen, D. Evidence for a better nodal staging system for melanoma: the clinical relevance of metastatic disease confined to the sentinel lymph nodes. Annals of surgical oncology. 20(2) : 668-74, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23054112
  • Egger, ME.Callender, GG.McMasters, KM.Ross, MI.Martin, RC.Edwards, MJ.Urist, MM.Noyes, RD.Sussman, JJ.Reintgen, DS.Stromberg, AJ.Scoggins, CR. Diversity of stage III melanoma in the era of sentinel lymph node biopsy. Annals of surgical oncology. 20(3) : 956-63, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23064795
  • Howard, JH.Thompson, JF.Mozzillo, N.Nieweg, OE.Hoekstra, HJ.Roses, DF.Sondak, VK.Reintgen, DS.Kashani-Sabet, M.Karakousis, CP.Coventry, BJ.Kraybill, WG.Smithers, BM.Elashoff, R.Stern, SL.Cochran, AJ.Faries, MB.Morton, DL. Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Annals of surgical oncology. 19(8) : 2547-55, 2012. http://www.ncbi.nlm.nih.gov/pubmed/22648554
  • Murray, L.Reintgen, M.Akman, K.Cox, C.Cox, J.Reintgen, D.Greenberg, H.Vrcel, V. Pleomorphic lobular carcinoma in situ: treatment options for a new pathologic entity. Clinical breast cancer. 12(1) : 76-9, 2012. http://www.ncbi.nlm.nih.gov/pubmed/22037287